Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cryobiology|July 22, 2004
Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancerBo H Chao, Xiaoming He, John C Bischof
Thrombosis|November 16, 2011
Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomesBo H Chao, Lisa Lepeak, Ticiana Leal, et al.
Molecular Cancer Therapeutics|April 18, 2009
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737Paula Hauck, Bo H Chao, Julie Litz, et al.
American Journal of Hematology|May 31, 2007
Fatal Loeffler's endocarditis due to hypereosinophilic syndromeBo H Chao, Karen Cline-Parhamovich, John D Grizzard, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.
Future Oncology (London, England)|August 11, 2022
LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA <i>RET</i> fusion-positive non-small-cell lung cancerMasahiro Tsuboi, Jonathan W Goldman, Yi-Long Wu, et al.
Frontiers in Oncology|June 5, 2023
Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage Jonathan W Goldman, Lynette M Sholl, Sanja Dacic, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2018
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLCDavid R Spigel, Jamie E Chaft, Scott Gettinger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2020
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLCRoy S Herbst, Hendrik Tobias Arkenau, Johanna Bendell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive <i>EGFR</i>-mutant Non-small Cell Lung CancerHelena A Yu, Luis G Paz-Ares, James Chih-Hsin Yang, et al.
Pageof 2